All together, these data show that patients with nonmuscle-invasive bladder cancer, with tendency for recurrence present a significant augment in ST3Gal.I and reduction in ST3Gal.II expression in their tumors. The gene discussed is ST3GAL1; the disease is urinary bladder carcinoma.